Healthcare ETF XLV Grinds Sideways as AI Mania Diverts Flows—Is Rotation on Deck?

There’s a certain irony in watching the healthcare sector, once the darling of defensive rotation, grind to a dead halt while the rest of the market chases AI unicorns and meme stock dreams. The XLV ETF hasn’t moved an inch, literally, $147.83 flat for the session, and not a blip of volatility to be found. For a sector that’s supposed to be a safe haven when the macro winds get choppy, this kind of inertia is more than just boring. It’s a signal that traders are either asleep at the wheel or waiting for something big to break.

The news flow is all AI, all the time. Wall Street is obsessed with tech IPOs, single-stock volatility is spiking, and even the Fed is openly admitting to a 'stress test' of its credibility. Meanwhile, healthcare is the wallflower at the party, ignored and unloved. The price action is proof: XLV hasn’t budged, with a 0% move on the day and barely any volume. This isn’t just a slow tape, it’s a market that’s been left behind.

Zoom out, and the context gets even more interesting. Healthcare stocks outperformed in 2022 and 2023 as investors rotated out of tech and into defensives. But as AI fever took hold, flows reversed. The last six months have seen a steady trickle of outflows from healthcare ETFs, with money pouring into anything with a whiff of artificial intelligence. The result is a sector that’s cheap on a relative basis, but still can’t find a bid. The big question: is this the bottom for healthcare, or is there more pain to come?

The data doesn’t lie. XLV is trading at a discount to its five-year average multiple, but earnings growth has stalled. The sector is caught between a rock (rising input costs, regulatory risk) and a hard place (investor apathy). At the same time, the macro backdrop is shifting. If the AI bubble pops, or if macro volatility returns, healthcare could be the first place money flows back into. But until then, the sector is stuck in purgatory.

The real story here is not that healthcare is boring. It’s that the market is pricing in a future where defensives don’t matter. That’s a dangerous assumption, especially with the Fed openly admitting to a credibility crisis and single-stock volatility at record highs. When the music stops, traders will scramble for safety, and healthcare is still the classic hideout. The only question is when, not if, the rotation begins.

Strykr Watch

Technically, XLV is boxed in a tight range between $146 and $150, with the 200-day moving average acting as a magnet at $148. RSI is stuck around 50, signaling indecision. There’s no momentum, but also no sign of a breakdown. Option implied vols are scraping the bottom, with skew favoring upside calls. For traders, this is a classic wait-and-see setup. The first move out of the range will be the tell.

The risks are obvious. If AI mania continues, healthcare could remain unloved for months. Regulatory risk is always lurking, especially in an election year. And if inflation surprises to the upside, input costs could squeeze margins. But the biggest risk is apathy, if no one cares, the sector could drift lower by default.

For those willing to take the other side, the opportunity is clear. Accumulating XLV near the bottom of the range with tight stops makes sense, especially if you believe in mean reversion. If the sector catches a bid, the move could be fast as underweight managers scramble to get exposure. Conversely, a breakdown below $146 could trigger a flush, offering a short setup for the nimble.

Strykr Take

Healthcare is the forgotten sector, but that’s exactly when you want to start paying attention. The rotation back into defensives will happen when no one expects it. For now, keep your powder dry and your stops tight. When the turn comes, you’ll want to be first, not last, on the bid.